Brief: Marksans Pharma Says UK Subsidiary Receives Marketing Authorization For Cetirizine
20/11/2025 08:32
Nov 20 (Reuters) - Marksans Pharma Ltd MARK.NS: UK SUBSIDIARY RECEIVES MARKETING AUTHORIZATION FOR CETIRIZINE Source text: ID:nBSE6XVGS Further company coverage: MARK.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg